The presence of isocitrate dehydrogenase 1 (IDH1) and 2 (IDH2) mutations has been observed in diffuse astrocytomas (WHO grade II) and anaplastic astrocytomas (WHO grade III). Here, IDH1 is linked to diffuse astrocytoma.